mk 0663 has been researched along with Inflammation in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustyniak, ME; Earl, RA; Garvey, DS; Janero, DR; Khanapure, SP; Letts, LG; Martino, AM; Murty, MG; Schwalb, DJ; Shumway, MJ; Trocha, AM; Young, DV; Zemtseva, IS | 1 |
| Beswick, PJ; Bingham, S; Bountra, C; Carter, MC; Chambers, LJ; Chessell, IP; Clayton, NM; Collins, SD; Corfield, JA; Gleave, RJ; Green, RH; Hartley, CD; Kleanthous, S; Lambeth, PF; Lucas, FS; Mathews, N; Naylor, A; Page, LW; Payne, JJ; Pegg, NA; Price, HS; Skidmore, J; Stevens, AJ; Stocker, R; Stratton, SC; Stuart, AJ; Swarbrick, ME; Wiseman, JO | 1 |
| Castrejón-Flores, JL; Franco-Hernández, MO; García-Aranda, MI; García-Báez, EV; Gómez-Castro, CZ; Gómez-Gómez, YM; Gonzalez-Padilla, JE; Padilla-Martínez, II; Rosales-Hernández, MC | 1 |
| Hamed, NS; Khateeb, S; Taha, EF | 1 |
| Ghosh, T; Sil, S | 1 |
| Dave, V; Sharma, S; Srivastava, P; Tak, K | 1 |
| Balgoma, D; Billing, B; Daham, K; Dahlén, B; Dahlén, SE; FitzGerald, GA; Henriksson, E; James, A; Kupczyk, M; Lindeberg, A; Wheelock, CE | 1 |
| Arora, SK; Khanduja, KL; Medhi, B; Pandhi, P; Rao, RS; Saikia, UN; Toor, JS | 1 |
| Micu, MC; Micu, R; Ostensen, M | 1 |
| Hilário, MO; Len, CA; Terreri, MT | 1 |
1 review(s) available for mk 0663 and Inflammation
| Article | Year |
|---|---|
Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors.
Topics: Adolescent; Aspirin; Celecoxib; Child; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Interactions; Etoricoxib; Fever; Humans; Hypersensitivity, Immediate; Inflammation; Leukotrienes; Meloxicam; Naproxen; Pain; Prostaglandins; Pyrazoles; Pyridines; Sulfonamides; Sulfones; Thiazines; Thiazoles; Treatment Outcome | 2006 |
1 trial(s) available for mk 0663 and Inflammation
| Article | Year |
|---|---|
Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma.
Topics: Adult; Allergens; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Cross-Over Studies; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Eosinophils; Etoricoxib; Female; Forced Expiratory Volume; Humans; Inflammation; Male; Methacholine Chloride; Middle Aged; Nitric Oxide; Prostaglandins; Pyridines; Sputum; Sulfones | 2014 |
8 other study(ies) available for mk 0663 and Inflammation
| Article | Year |
|---|---|
3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluation.
Topics: Administration, Oral; Animals; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Inflammation; Male; Prostaglandin-Endoperoxide Synthases; Pyridines; Rats; Rats, Sprague-Dawley; Sulfones | 2005 |
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors.
Topics: Amines; Animals; Brain; Chemistry, Pharmaceutical; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Design; Ethers; Humans; Inflammation; Inhibitory Concentration 50; Mice; Molecular Structure; Neurodegenerative Diseases; Pyrimidines; Rats; Sulfones | 2009 |
Anti-inflammatory effect and inhibition of nitric oxide production by targeting COXs and iNOS enzymes with the 1,2-diphenylbenzimidazole pharmacophore.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzimidazoles; Cattle; Cyclooxygenase 1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Humans; Inflammation; Male; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Structure-Activity Relationship | 2020 |
Etoricoxib nanostructured lipid carriers attenuate inflammation by modulating Cyclooxygenase-2 signaling and activation of nuclear factor-κB-p65 pathways in radiation-induced acute cardiotoxicity in rats.
Topics: Animals; Cardiotoxicity; Cyclooxygenase 2; Etoricoxib; Humans; Inflammation; Lipids; NF-kappa B; Rats | 2023 |
Etoricoxib inhibits peripheral inflammation and alters immune responses in intracerebroventricular colchicine injected rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cyclooxygenase 2; Etoricoxib; Inflammation; Injections, Intraventricular; Male; Rats; Tubulin Modulators | 2018 |
PEG-PLGA- hybrid nanoparticles loaded with etoricoxib - phospholipid complex for effective treatment of inflammation in rat model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Carriers; Drug Liberation; Etoricoxib; Inflammation; Male; Nanoparticles; Phospholipids; Polyesters; Polyethylene Glycols; Rats; Rats, Wistar | 2019 |
Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat.
Topics: Acetic Acid; Analysis of Variance; Animals; Arthritis; Colitis; Cyclooxygenase Inhibitors; Cytokines; Disease Models, Animal; DNA Fragmentation; Etoricoxib; Freund's Adjuvant; Immunosuppressive Agents; Inflammation; Male; Pyridines; Rats; Rats, Wistar; Seizures; Sulfones; Thalidomide | 2008 |
Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Chi-Square Distribution; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Female; Fertility; Humans; Ibuprofen; Infertility, Female; Inflammation; Norway; Ovarian Follicle; Ovulation; Pregnancy; Prospective Studies; Pyridines; Rheumatic Diseases; Risk Assessment; Risk Factors; Sulfones; Ultrasonography | 2011 |